Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

952 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy.
Koshkin VS, Danchaivijitr P, Bae WK, Semenov A, Ozyilkan O, Su YL, Arranz Arija JA, Tsujihata M, Bögemann M, Hendriks MP, Delgado SN, Rosenbaum E, Lopez KA, Bavle A, Liu CC, Imai K, Furka A. Koshkin VS, et al. Among authors: semenov a. Eur Urol. 2024 Dec 20:S0302-2838(24)02706-4. doi: 10.1016/j.eururo.2024.11.012. Online ahead of print. Eur Urol. 2024. PMID: 39709248
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302).
Lara PN Jr, Villanueva L, Ibanez C, Erman M, Lee JL, Heinrich D, Lipatov ON, Gedye C, Gokmen E, Acevedo A, Semenov A, Park SH, Gafanov RA, Kose F, Jones M, Du X, Munteanu M, Perini R, Choueiri TK, Motzer RJ. Lara PN Jr, et al. Among authors: semenov a. BMC Cancer. 2024 Jul 25;23(Suppl 1):1253. doi: 10.1186/s12885-023-10971-7. BMC Cancer. 2024. PMID: 39054430 Free PMC article. Clinical Trial.
Membrane-Active Singlet Oxygen Photogenerators as a Paradigm for Broad-Spectrum Antivirals: The Case of Halogenated (BOron)-DIPYrromethenes.
Maryewski XA, Krasilnikov MS, Straková P, Holoubek J, Frčková T, Panina IS, Krylov NA, Gvozdev DA, Denisov VS, Semenov AN, Lotosh NY, Selishcheva AA, Chistov AA, Gulyak EL, Kozhemyakin GL, Korshun VA, Efremov RG, Ustinov AV, Růžek D, Eyer L, Alferova VA. Maryewski XA, et al. Among authors: semenov an. ACS Appl Mater Interfaces. 2025 Jan 7. doi: 10.1021/acsami.4c17482. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39772406
Antioxidant properties of the soluble carotenoprotein AstaP and its feasibility for retinal protection against oxidative stress.
Lunegova DA, Gvozdev DA, Senin II, Gudkova VR, Sidorenko SV, Tiulina VV, Shebardina NG, Yakovleva MA, Feldman TB, Ramonova AA, Moysenovich AM, Semenov AN, Zernii EY, Maksimov EG, Sluchanko NN, Kirpichnikov MP, Ostrovsky MA. Lunegova DA, et al. Among authors: semenov an. FEBS J. 2024 Nov 24. doi: 10.1111/febs.17335. Online ahead of print. FEBS J. 2024. PMID: 39580658
952 results